Navigation LinksBiology NewsHealth NewsBiology TechnologyMedicine Technology


We're sorry, that page (http://www.bio-medicine.org/biology-technology-1/esperance-pharmaceuticals-announces-initiation-of-clinical-studies-of-its-novel-membrane-disrupting-agent--ep-100--in-patients-with-cancer-13972-3/;+health+history;+medical+history.html) was not found.

Search biology technology 1 esperance pharmaceuticals announces initiation of clinical studies of its novel membrane disrupting agent ep 100 in patients with cancer 13972 3 ;+health+history;+medical+history html at Google

Search biology technology 1 esperance pharmaceuticals announces initiation of clinical studies of its novel membrane disrupting agent ep 100 in patients with cancer 13972 3 ;+health+history;+medical+history html at Yahoo

Search biology technology 1 esperance pharmaceuticals announces initiation of clinical studies of its novel membrane disrupting agent ep 100 in patients with cancer 13972 3 ;+health+history;+medical+history html at Msn

Google
 
(Date:12/2/2009)...ILADELPHIA Exposure to secondhand smoke for a pro...rease the risk of breast cancer, even in women who...stion of whether exposure to side-stream smoke cou...nresolved," said Peggy Reynolds, Ph.D., senior res...Center,s Berkeley office. "While no single epidemi...
(Date:12/2/2009)...lls of ground beef, peanut butter, and other foods...ncern about food safety. They also are quietly fue...nt and fostering new food safety regulations. That...rrent issue of Chemical & Engineering News , (C&E...itor Jyllian Kemsley and Senior Correspondent Marc...
(Date:12/2/2009)..., N.C. Duke University Medical Center researchers...brain cancer glioma may be better able to resist r...icular signaling pathway in these cancer stem cell...ith radiation in a laboratory experiment. , The...t cancer stem cells resist the effects of radiatio...
Breaking Biology News(10 mins):Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Discovery makes brain tumor cells more responsive to radiation 2Resuscitation and Survival Rates from Out of Hospital Cardiac Arrest Nearly Double with Comprehensive Treatment Protocol 61476 1Resuscitation and Survival Rates from Out of Hospital Cardiac Arrest Nearly Double with Comprehensive Treatment Protocol 61476 2Resuscitation and Survival Rates from Out of Hospital Cardiac Arrest Nearly Double with Comprehensive Treatment Protocol 61476 3Resuscitation and Survival Rates from Out of Hospital Cardiac Arrest Nearly Double with Comprehensive Treatment Protocol 61476 4Resuscitation and Survival Rates from Out of Hospital Cardiac Arrest Nearly Double with Comprehensive Treatment Protocol 61476 5Resuscitation and Survival Rates from Out of Hospital Cardiac Arrest Nearly Double with Comprehensive Treatment Protocol 61476 6United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results 61473 1United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results 61473 2United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results 61473 3United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results 61473 4United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results 61473 5United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results 61473 6United American Healthcare Corporation Announces Fiscal 2010 First Quarter Results 61473 7China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 61470 1China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 61470 2China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 61470 3China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 61470 4China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 61470 5China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 61470 6China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 61470 7China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 61470 8China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 61470 9China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 61470 10China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 61470 11
(Date:12/4/2009)... , , REDWOOD CITY, Calif., Dec. 4 /PRNew... GHDX ) today announced that the company will pres...an Antonio Breast Cancer Symposium (SABCS), taking...ez Convention Center. Four of the studies analyze...ression test that physicians currently use to pred...
(Date:12/4/2009)... , InfoLogic today announ...nning multi-purpose equation editor. With a focus ... Personal Edition is a standalone equation editor ...reads and writes various industry standard mathema...ion 4.8 adds support for Google Docs and Zoho Writ...
(Date:12/4/2009)... , North American Seminar...sh to host continuing medical education courses at...ws a facility to showcase its operation and capabi...their overall costs to educate their physical ther... over 45 facilities hosted over 250 live training ...
(Date:12/4/2009)... , Plantar fasciitis heel...d Stated each year, and cold therapy has been cite...s an effective treatment option. In response to t...election of compressive cold therapy systems for p...line of combination night splint therapies. , ...
(Date:12/4/2009)... , The renowned Center fo.... is now offering the only natural immuno-boosting...rinciples of Ayurveda. , ...In this age of unprecedented illness due to factor...influenza strain millions of people around the wor...
Breaking Medicine News(10 mins):Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 2Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 3Health News:Genomic Health to Present Five New Studies at 32nd Annual San Antonio Breast Cancer Symposium 4Health News:MathMagic Personal 4.8 for Windows Now Supports Google Docs and Zoho Equation 2Health News:MathMagic Personal 4.8 for Windows Now Supports Google Docs and Zoho Equation 3Health News:MathMagic Personal 4.8 for Windows Now Supports Google Docs and Zoho Equation 4Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 2Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 4Health News:Orthotics And Beyond Introduces Compressive Cold Therapy Products for Plantar Fasciitis Treatment 2Health News:The Chopra Center for Wellbeing Launches Vedamune: An Ayurvedic Supplement to Support The Immune System 2
...orter 2, Neuronal (GLYT2). The antiserum has been ... system. The staining pattern obtained with AB1773...u hybridization with probes to GLYT2 mRNA and to w...eabsorption of the antiserum with the immunogen pe...
MMP-2 Inhibitor I from Calbiochem
Mouse Anti-Parainfluenza Virus type 2 Monoclonal Antibody, Unconjugated, Clone 1241 from Novus Biologicals
Mouse Anti-PCTAIRE 2 Monoclonal Antibody, Unconjugated, Clone 0.N.509 from Abcam
Biology Products:
Sabre 2400 Electrosurgery Generator, 110V, 60Hz
ExcaliburPlus PC Electrosurgery Generator, 220V, 50Hz
Bipolar Generator
Finesse Electrosurgical Generator (200-240 VAC)
Medicine Products:
(Date:12/3/2009)... , TUSTIN, Calif., Dec. 3 /PRNewswire-Fir...: PPHM ) today announced that it will release its...l year 2010 on December 10, 2009 at 7:00 a.m. EST ...cuss the results at 11:30 a.m. EST on the same day... financial results for the second quarter ended Oc...
(Date:12/3/2009)... , HOPKINTON, Mass., Dec. 3 /PRNewswire-Fir...ALP ), a leading provider of tools and services fo... introduced Living Image 4.0 software for IVIS...drives the more than 800 Caliper IVIS systems curr...Image 4.0 features advanced spectral unmixing tool...
(Date:12/2/2009)... , COLUMBIA, Md., Dec. 2 /PRNewswire-FirstC...ATK ) announced today that it intends to release t...009 on December 16, 2009, at approximately 4:00 p....:45 p.m. ET Martek will conduct a conference call ...rested parties may listen to the call live via web...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Rep... report is available in its catalogue: ,, Neur... http://www.reportlinker.com/p0164232/Neurostimula...e world neurostimulation market stands enthused by...ultant rise in age-related diseases such as, Parki...
Breaking Biology Technology:Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6
(Date:12/4/2009)...DA, Md., Dec. 4 Drs. Neal Shore an...-specific antigen (PSA) recurrence from the additi...al recurrence rate in a Phase III pivotal study of...or monthly leuprolide in prostate cancer patients ...er patients who received FIRMAGON 240/80 mg/month ...
(Date:12/4/2009)...AN, N.J., Dec. 4 Depression, anxie...yperactivity Disorder (ADHD), sleep disorder and m...d to occur more often in people who said they had ...an epilepsy diagnosis, according to a survey of ap..., Findings from " CNS-Related Comorbidities in In...
(Date:12/3/2009)...O VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 /PR... announced the signing of an agreement to provide ...ftGenetics, NextGENe software for next-generation ...ogo: http://www.newscom.com/cgi-bin/prnh/2009042...s CSO said, "Our team at Ambry has been providing ...
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3Senesco Technologies Inc Announces Management Change 14857 1Senesco Technologies Inc Announces Management Change 14857 2Senesco Technologies Inc Announces Management Change 14857 3Cyberonics Provides Update on Tax Position 6313 1Cyberonics Provides Update on Tax Position 6313 2Cyberonics Provides Update on Tax Position 6313 3Cyberonics Provides Update on Tax Position 6313 4Retirement Living TV Premieres Season Two of Whole Body Health 6310 1Retirement Living TV Premieres Season Two of Whole Body Health 6310 2